Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.
Vaxdyn has raised $13.1M in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Vaxdyn's investors include CARB-X, Reig Jofre, Arquimea Ingeniera, EIC Accelerator, Bionova Capital.
Vaxdyn is headquartered in Sevilla, Spain.
Vaxdyn is a developer of multi-valent vaccines for preventing antibiotics-resistant infections.
Vaxdyn is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vaxdyn — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/vaxdyn. Accessed August 17, 2026.
VCBacked. (2024). Vaxdyn — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/vaxdyn
{{cite web |title=Vaxdyn — Funding & Investors |url=https://www.vcbacked.co/company/vaxdyn |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated